Golvatinib
Product Specifications
CAS Number
928037-13-2
Target
C-Met/HGFR, VEGFR
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis
Purity
0.995
Bioactivity
Golvatinib (E-7050) is an orally bioavailable dual kinase inhibitor of c-Met (hepatocyte growth factor receptor) and VEGFR-2 (vascular endothelial growth factor receptor-2) tyrosine kinases with potential antineoplastic activity. c-Met/VEGFR kinase inhibitor E7050 binds to and inhibits the activities of both c-Met and VEGFR-2, which may inhibit tumor cell growth and survival of tumor cells that overexpress these receptor tyrosine kinases. c-Met and VEGFR-2 are upregulated in a variety of tumor cell types and play important roles in tumor cell growth, migration and angiogenesis.
Smiles
CN1CCN(CC1)C1CCN(CC1)C(=O)Nc1cc(Oc2ccc(NC(=O)C3(CC3)C(=O)Nc3ccc(F)cc3)c(F)c2)ccn1
Molecular Formula
C33H37F2N7O4
Molecular Weight
633.69
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
33079124 3x 1.0µg DNA
Olfr338 CRISPRa sgRNA lentivector (set of three targets)(Mouse)
Sign In for Pricing
View Details 
VD2N557 1 Each
Rabbit Anti-Mouse Early Growth Response Protein 2 (EGR2) Polyclonal Antibody
Sign In for Pricing
View Details 
bsm-61615R-Cy3-01 20 µL
COUP-TF1 Recombinant Antibody, Cy3 Conjugated
Sign In for Pricing
View Details bsm-61615R-Cy3-02 100 µL
COUP-TF1 Recombinant Antibody, Cy3 Conjugated
Sign In for Pricing
View Details 